Citigroup
GLSI icon

Citigroup’s Greenwich LifeSciences GLSI Stock Holding History

Citigroup’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.17K Buy
340
+113
+50% +$2.95K ﹤0.01% 5118
2025
Q4 		$4.77K Sell
227
-38
-14% -$400 ﹤0.01% 5256
2025
Q3 		$2.64K Sell
265
-1,901
-88% -$21.5K ﹤0.01% 5413
2025
Q2 		$19.6K Sell
2,166
-2,173
-50% -$20.7K ﹤0.01% 5082
2025
Q1 		$41.4K Sell
4,339
-540
-11% -$6.55K ﹤0.01% 4930
2024
Q4 		$54.8K Buy
4,879
+571
+13% +$7.64K ﹤0.01% 5062
2024
Q3 		$61.9K Buy
4,308
+3,009
+232% +$44.6K ﹤0.01% 4956
2024
Q2 		$22.4K Sell
1,299
-6,958
-84% -$102K ﹤0.01% 4974
2024
Q1 		$165K Sell
8,257
-1,267
-13% -$15.6K ﹤0.01% 4105
2023
Q4 		$100K Buy
+9,524
New +$95.5K ﹤0.01% 4198
2023
Q2 		– Sell
-12,498
Closed -$172K – 5627
2023
Q1 		$172K Buy
+12,498
New +$198K ﹤0.01% 3802
2022
Q3 		– Sell
-34
Closed – – 6014
2022
Q2 		$0 Sell
34
-115
-77% -$1.32K ﹤0.01% 6383
2022
Q1 		$3K Sell
149
-884
-86% -$17.9K ﹤0.01% 5959
2021
Q4 		$25K Sell
1,033
-605
-37% -$20.2K ﹤0.01% 5330
2021
Q3 		$64K Buy
1,638
+27
+2% +$1.13K ﹤0.01% 4609
2021
Q2 		$72K Buy
1,611
+1,096
+213% +$41.4K ﹤0.01% 4644
2021
Q1 		$18K Buy
+515
New +$17.5K ﹤0.01% 5312

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Citigroup's GLSI Position: Q1 2026 in Review

Citigroup increased its Greenwich LifeSciences (GLSI) stake by 50% in Q1 2026, buying an estimated $2.95K and bringing the position to 340 shares worth $8.17K. The position accounts for ﹤0.01% of the portfolio, ranked #5118.

Citigroup first reported a position in GLSI in Q1 2021 and has held it in 17 quarters since. The position peaked at $172K in Q1 2023. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Citigroup held 340 shares of Greenwich LifeSciences worth $8.17K as of Q1 2026.
  • Citigroup bought 113 Greenwich LifeSciences shares in Q1 2026, an estimated $2.95K.
  • Greenwich LifeSciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5118 holding.
  • Citigroup first reported a position in Greenwich LifeSciences in Q1 2021 and has held it in 17 quarters since.
  • Citigroup's Greenwich LifeSciences position peaked at $172K in Q1 2023.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.